It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
AIM OF THE STUDY: This study aimed to analyze the daily clinical practice of primary care practitioners (PCPs) in Poland concerning migraine patients.
CLINICAL RATIONALE FOR THE STUDY: Migraine is a common chronic primary headache disease, which can be disabling if insufficiently managed. Numerous studies suggest that migraine remains underdiagnosed and undertreated. The first consultation of migraine patients is usually undertaken by a PCP.
MATERIALS AND METHODS: This study was conducted in June and July 2019 in Poland using a computer-assisted web interview with 51 PCPs. The interview questions concerned knowledge of diagnostic criteria and methods of migraine treatment.
RESULTS: On average, each PCP consulted 12 patients with migraine per month. More than half of PCPs (63%) listed partial diagnostic criteria for migraine without aura or mentioned aura in their responses. Only 10% of PCPs listed all diagnostic criteria for migraine without aura. Although 55% of PCPs said that they distinguished between episodic and chronic migraine, 18% provided the wrong definition. The most commonly prescribed drugs were triptans (66%), paracetamol, metamizole, or non-steroidal anti-inflammatory drugs (42%).
CONCLUSIONS AND CLINICAL IMPLICATIONS: PCPs play a critical role in diagnosing, treating, and monitoring migraine; however, many of them have insufficient knowledge about its diagnosis and correct differentiation between chronic and episodic forms.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Department of Neurology, Faculty of Medical Sciences, Medical University of Warsaw, Warsaw, Poland, Cegłowska 80, 01-809 Warsaw, Poland. [email protected]
2 Medical Department, Teva Pharmaceuticals Polska Sp. z o.o.,, Emilii Plater 53,, 00-113 Warsaw, Poland
3 Department of Neurology, Stroke, and Neurorehabilitation, Medical University of Lodz,, Kopcińskiego 22, 90-153 Lodz, Poland
4 Department of Neurology, Military Institute of Medicine in Warsaw, Szaserów 128, 04-141 Warsaw, Poland
5 Department of Neurology, Charles Marcinkowski University of Medical Sciences, Przybyszewskiego 49, 60-355 Poznan, Poland